[Abdominal variant of drug-induced anaphylactic shock].

[Conductive hearing loss caused by eustachian tube dysfunction according to the data of functional computed tomography]. Vestn Rentgenol Radiol (2012) 0.78

[Hemorrhage following tonsillectomy: analysis of the prevalence and risk factors]. Vestn Otorinolaringol (2013) 0.76

[Peculiarities of the surgical treatment of nasal septum perforations]. Vestn Otorinolaringol (2012) 0.76

[Levocetirizine in therapy for allergic rhinitis]. Vestn Otorinolaringol (2010) 0.75

[The evolution of adenoidectomy]. Vestn Otorinolaringol (2013) 0.75

[The estimation of the efficacy of manual therapy included in the combined treatment of cochlear-vestibular disorders based on the results of computed stabilography]. Vestn Otorinolaringol (2012) 0.75

[Organ-sparing treatment of polypous sinusitis]. Vestn Otorinolaringol (1987) 0.75

[Application of the navigation system in endoscopic surgery of paranasal sinuses and base of the skull]. Vestn Otorinolaringol (2005) 0.75

[Endoscopic surgical treatment of vascular tumors of the paranasal sinuses and base of the skull]. Vestn Otorinolaringol (2008) 0.75

[The olfactory function in the patients with the curved nasal septum before and after surgical treatment]. Vestn Otorinolaringol (2011) 0.75

[Diagnosis of anaphylactic shock caused by antibiotics]. Antibiotiki (1977) 0.75

[Olfactory disorders and their correction]. Vestn Otorinolaringol (2007) 0.75

[Secondary operations for the treatment of nasal septum deformities]. Vestn Otorinolaringol (2013) 0.75

[The effectiveness of long-term treatment of polypous rhinosinusitis with low doses of macrolides]. Vestn Otorinolaringol (2013) 0.75

[The anti-inflammatory properties of fusafungine]. Vestn Otorinolaringol (2010) 0.75

[Endonasal endoscopic orbital decompression through the transethmoidal approach]. Vestn Otorinolaringol (2009) 0.75

[Efficacy of the drug IRS 19 in prophylaxis of complications in rhinosurgical interventions]. Vestn Otorinolaringol (2006) 0.75

[A new variant of choanal polyps]. Vestn Otorinolaringol (2001) 0.75

[The state of the stirrup prosthesis estimated from the results of functional multispiral computed tomography]. Vestn Otorinolaringol (2012) 0.75

[Experience with the use of magnetic nanoparticles in medicine and prospects for their application in otorhinolaringology]. Vestn Otorinolaringol (2009) 0.75

[Efficiency of sinuforte in combined therapy of acute suppurative rhinosinusitis]. Vestn Otorinolaringol (2009) 0.75

[Control and study of drug side effects in therapeutic institutions]. Sov Med (1980) 0.75

[The influence of the surgical and medicamental treatment on the olfactory function in the patients presenting with polypous rhinosinusitis]. Vestn Otorinolaringol (2012) 0.75

[Spontaneous nasal liquorrhea and the Sternberg canal: scientific hypothesis and personal experience]. Vestn Otorinolaringol (2014) 0.75

[The role of the topical corticosteroid therapy in the treatment of chronic polypous rhinosinusitis]. Vestn Otorinolaringol (1999) 0.75

[Endoscopic diagnosis and treatment of nasal rhinorrhea]. Vestn Otorinolaringol (2003) 0.75

[Main principles of functional intranasal surgery of paranasal sinuses]. Vestn Otorinolaringol (1996) 0.75

[Nasonex effectiveness in allergic rhinitis and chronic polypous rhinosinusitis]. Vestn Otorinolaringol (2000) 0.75

[The nasal valve. Part II. The modern methods for the conservative and surgical treatment of its pathology]. Vestn Otorinolaringol (2012) 0.75

[Maxillary puncture: endoscopic assessment]. Vestn Otorinolaringol (2006) 0.75

[A device for careful probing of the frontal sinus]. Vestn Otorinolaringol (1987) 0.75

[The incidence of detecting paranasal sinus pathology based on magnetic resonance and computed tomographic data]. Vestn Otorinolaringol (1997) 0.75

[The Hummer Microdebrider--new technology in functional endonasal rhinosurgery]. Vestn Otorinolaringol (1997) 0.75

[Ebastine (kestine 20) in therapy of allergic rhinitis]. Vestn Otorinolaringol (2007) 0.75

[Functional multispiral computed tomography of sound-transmitting structures in the middle ear]. Vestn Otorinolaringol (2011) 0.75

[The nasal valve. Part I. Anatomical and physiological nature, clinical manifestations of dysfunction and methods for its diagnostics]. Vestn Otorinolaringol (2012) 0.75

[Giant laryngopharyngeal angiofibroma and an organ-sparing method for its removal]. Vestn Otorinolaringol (1986) 0.75

[Anti-inflammatory therapy of paranasal sinuses diseases]. Vestn Otorinolaringol (2006) 0.75

[The results of the surgical treatment of otosclerosis in the elderly subjects]. Vestn Otorinolaringol (2014) 0.75

[Potentials for the endonasal endoscopic surgery in the treatment of maxillary cysts]. Vestn Otorinolaringol (2000) 0.75

[The problem of drug side effects]. Ter Arkh (1992) 0.75

[Therapy of imudon after tonsillectomy]. Vestn Otorinolaringol (2006) 0.75

[Drugs do not cause diseases]. Sov Med (1984) 0.75

Consensus Conference on Nasal Polyposis. Acta Otorhinolaryngol Ital (2004) 0.75

[Clinical and statistical analysis of the side effects and complications of antibiotic therapy]. Antibiotiki (1977) 0.75

[The assessment of the state of the immune system in the patients presenting with bronchial asthma and concomitant diseases of the nasal cavity and paranasal sinuses]. Vestn Otorinolaringol (2012) 0.75

[Characteristics of drug-induced anaphylactic shock]. Sov Med (1985) 0.75

[The potential of multislice computed tomography for the detection of specific anatomic and topographic features of the facial nerve canal prior to stapedoplasty]. Vestn Otorinolaringol (2012) 0.75

[The use of functional multispiral computed tomography for differential diagnostics of otosclerosis and congenital malformation of the internal and middle ear (a case report)]. Vestn Otorinolaringol (2012) 0.75

[Polysomnographic results of surgical treatment of obstructive apnea syndrome]. Vestn Otorinolaringol (2003) 0.75

[Combined treatment of productive forms of chronic polysinusitis]. Vestn Otorinolaringol (1986) 0.75

[Oropharyngeal candidiasis in the practical work of the otorhinolaryngologist]. Vestn Otorinolaringol (2010) 0.75

[Chronic rhinosinusitis: epidemiology, classification, etiology, and pathogenesis. The current view of the problem]. Vestn Otorinolaringol (2012) 0.75

[Treatment of status epilepticus with the intravenous administration of aminazine]. Zh Nevropatol Psikhiatr Im S S Korsakova (1968) 0.75

[Peculiarities of sanitizing middle ear reoperations]. Vestn Otorinolaringol (2009) 0.75

[Endoscopic rhinosurgery: from simple intranasal surgery to interventions on orbital apex and base of the skull]. Vestn Otorinolaringol (2009) 0.75

[Efficacy of perioperative prophylaxis with bioparox in surgical interventions on the nasal cavity and paranasal sinuses]. Vestn Otorinolaringol (2006) 0.75

[Application of sinuforte in domestic and foreign practices]. Vestn Otorinolaringol (2010) 0.75

[Pattern of ENT problems in patients with primary defects of humoral immunity]. Vestn Otorinolaringol (2002) 0.75

[Endoscopic endonasal diagnosis and treatment of basal liquorrhea and encephalocele of the anterior regions of the skull base]. Zh Vopr Neirokhir Im N N Burdenko (2002) 0.75

[The influence of different methods of surgical intervention on mucosal microcirculation in the inferior turbinate bone evaluated by laser Doppler flowmetry]. Vestn Otorinolaringol (2009) 0.75

[Our experience with the application of collagen-based preparations in reconstructive surgery of the middle ear]. Vestn Otorinolaringol (2012) 0.75

[Tonsillectomy in children: how it is performed in Europe and America?]. Vestn Otorinolaringol (2013) 0.75

[Avelox efficacy in the treatment of acute purulent rhinosinusitis]. Ter Arkh (2007) 0.75